Auto-antibodies Flashcards

1
Q

Anti-nuclear Antibody

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ssDNA

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

c1q

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiolipin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Centromere

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

dsDNA

A

Presence of high-titer anti–double-stranded (DS) antibodies is not specific for drug-induced lupus, with the exception of systemic lupus erythematosus (SLE) induced by anti–tumor necrosis factor (TNF) agents (adalimumab, infliximab, and etanercept). In anti–TNF agent induced SLE, anti-DSDNA antibodies may be present in up to 90% of the cases. Some patients who develop anti–TNF agent induced lupus have been successfully switched to a different anti–TNF agent without recurrence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Histone

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ku

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

La/SSB

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

a-fodrin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MDA5/CADM-140

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mi-2

A

Classic: gottron papules, gottron sign, shawl sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

p140

A

2 malignant adult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

p155

A

Anti-TIF1 antibodies are associated with severe photosensitive cutaneous findings, palmar hyperkeratosis, psoriasiform dermatitis, and the development of solid and hematologic malignancies.

Also associated w/ cutaneous symptoms (heliotrope, Gottron’s, flagellate erythema)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

RNA polymerase

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ro/SSA

A

Also seen in SCLE w/ photosensitivity

17
Q

rRNP

A
18
Q

Scl-70

A
19
Q

Smith

A
20
Q

SRP

A

DM - severe proximal muscle weakness

21
Q

Synthetase

A
22
Q

U1RNP

A
23
Q

ECM1 (extracellular matrix protein 1)

A

Lichen sclerosis (correlates with disease activity)

24
Q

Myositis antibodies

A
25
Q

Jo1

A

Target: directed against the histidyl-tRNA synthetase which catalyses the binding of the histidine to its cognate tRNA during protein synthesis

Dermatomyositis with pulmonary fibrosis, Raynaud’s, polyarthritis

26
Q

Complement deficiencies

A